1460 / 1816
Restaging the axilla
•
Invasive re-staging:
•
SN after PST – with confirmatory ALND
•
SENTINA trial
1
; ACOSOG Z1071
2
and FNAC trial
3
•
Prospective cohort study
4
(no ALND if ≥ 3 SN negative)
•
Removal of clipped pathological node – with confirmatory ALND
•
MARI
5
(Marking of the Axilla with Radioactive Iodine)
•
Clipped node i.c.w. SN
2,6
•
RISAS study: recruiting
1
Kuehn et al 2013;
2
Boughey et al 2013, 2016, 2017
3
Boileau
et al 2015;
4
Mamtani et al 2016;
5
Donker et al 2015;
6
Caudle
et al 2016.